Identifying progression of retinal disease in eyes with NPDR in diabetes type 2 using non-invasive procedures [more info]

Prospective, randomized, multicenter, open label phase II study to access efficacy and safety of Lucentis® monotherapy (ranibizumab 0.5 mg intravitreal injections) compared with Lucentis® plus panretinal photocoagulation (PRP) and PRP (monotherapy) in the treatment of patients with high risk proliferative diabetic retinopathy [more info]

Epidemiological study of the prevalence of age-related macular degeneration in Portugal [more info]

Double blind randomized multicenter placebo-controlled, parallel-group designed clinical trial of the efficacy and tolerability of Cloricromene Hydrochloride capsules 100 mg tid in Diabetic Patients with mild to moderate non-profilerative retinopathy [more info]